Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

A white and black clock face is shown with three hands saying Time to Buy reflecting Citi's view that it's time to buy ASX 200 banks

Image source: Getty Images

News Corp (ASX: NWS)

According to a note out of Goldman Sachs, its analysts have retained their conviction buy rating and increased their price target on this media giant's shares to $44.50. This follows the release of its full year result last week. And while News Corp fell a touch short of its expectations, the broker remains very positive on its outlook. It is forecasting operating earnings growth of 17% in FY 2022. It also believes share buybacks could unlock value for shareholders. The News Corp share price is trading at $32.37 today.

REA Group Limited (ASX: REA)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $185.00 price target on this property listings company's shares. Morgan Stanley was pleased with REA's FY 2021 result. And while it suspects that its first half result could be a touch softer than expected in FY 2022 because of lockdowns, it expects listing volumes to rebound quickly. In light of this, it appears to believe any short term share price weakness would be a buying opportunity. The REA share price is fetching $154.24 today.

ResMed Inc (ASX: RMD)

Analysts at Morgans have retained their add rating and lifted their price target on this sleep treatment company's shares by almost 42% to $41.34. This follows the release of a stronger than expected fourth quarter update last week. It also notes that management expects a US$300 million to US$350 million revenue benefit in FY 2022 from the product recall by rival Philips. The broker notes that this has led to unsatisfied demand everywhere. Though, Morgans acknowledges that bottlenecks in the supply chain could limit the benefit from pent-up demand for devices. The ResMed share price is trading at $37.77 today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
Broker Notes

Buy, hold, sell: Goodman Group, BHP, Westpac shares

ASX 200 shares are in the red for a fifth consecutive session amid stalled peace talks between the US and…

Read more »

Business man marking Sell on board and underlining it
Broker Notes

Experts name 3 ASX 200 shares to sell now

Let's see which shares are being tipped as sells this week.

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Broker Notes

What is Morgans' updated view on Bank of Queensland and PLS shares?

These ASX 200 stocks are performing very differently this year.

Read more »

A construction worker sits pensively at his desk with his arm propping up his chin as he looks at his laptop computer.
Broker Notes

Are these ASX materials stocks a buy, hold or sell according to Morgans?

Morgans is optimistic on these shares.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Analysts pick 3 ASX 200 stocks to buy

These stocks have been given buy ratings this week. Here's what you need to know about them.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Three ASX 200 shares the Jarden team says are a buy right now

Looking for a bargain? These shares might fit the bill.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Brambles, CBA, and Macquarie shares

Do analysts rate these shares as buys? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »